Anemia Clinical Trials

Find Anemia Clinical Trials Near You

Early Iron Supplementation in Very Preterm Infants Fed Donor Breast Milk: A Prospective, Interventional, Clinical Trial

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this clinical trial is to determine the serum ferritin level and hematocrit level in very preterm infants receiving donor breast milk(DBM) with an early iron supplementation protocol . The main questions it aims to answer are: Does earlier iron supplementation provide increased ferritin levels at 14 and 28 days of life in subjects fed primarily donor breast milk? Iron supplementation will be implemented when the infant achieves 80ml/kg/day of enteral feeds, as contrasted to the current protocol of full feeds (140 to 160ml/kg/day), the latter usually by Day 14 of life. At day of life(DOL) 14 (± 4 days), a blood sample will be obtained for serum ferritin determination. Similarly, a second blood draw would be performed at day of life 28 (± 4 days) or prior to discharge, whichever comes earlier

Eligibility
Participation Requirements
Sex: All
Minimum Age: 6 months
Maximum Age: 7 months
Healthy Volunteers: f
View:

• 1\. All preterm infants born between 29.0-32.6 weeks of gestational age and admitted to the NICU at Advent Health for Children 2. Infants likely to be receiving DBM between 5 to 14 days of life 3. Infants receiving \>50% of the feeding volume by DBM will be considered to have received DBM.

Locations
United States
Florida
AdventHealth Orlando
RECRUITING
Orlando
Contact Information
Primary
Anoop Pulickal, MD, PhD
Anoop.Pulickal.MD@adventhealth.com
407-303-2528
Backup
Deborah Ruth, RN
deborah.ruth@adventhealth.com
407-303-9186
Time Frame
Start Date: 2026-05-06
Estimated Completion Date: 2027-12
Participants
Target number of participants: 17
Treatments
Experimental: Very preterm infants
Sponsors
Leads: AdventHealth

This content was sourced from clinicaltrials.gov